Ofatumumab plus chlorambucil versus chlorambucil alone in patients with untreated chronic lymphocytic leukaemia (CLL): results of the phase III study COMPLEMENT 1 (OMB110911; NCRN-adopted) - Hillmen, P; Pettitt, A; Schuh, A; Milligan, D; Bowles, K; Bareford, D; Riaz, J; Follows, G; Rule, S; Wallis, J; Gribben, J; Noble, R; et al. (2014)